Elders 2025 Notice of Annual General Meeting
Released
Released
Announcement PDF
Elders Limited ABN 34 004 336 636.
Registered Office: Level 10, 80 Grenfell Street, Adelaide SA Australia 5000
17 November 2025
Notice of 2025 Annual General Meeting
Attached is the notice of the Elders Limited (ASX:ELD) Annual General Meeting of shareholders to be held
on Thursday 18 December 2025, from 10.00am (ACDT).
Further Information:
Mark Allison, Managing Director & Chief Executive Officer, 0439 030 905
Authorised by:
Elders Limited Board of Directors
View this announcement on Elders’ Investor Hub.
ELDERSANNUAL
GENERALMEETING
Notice is hereby given that the 71st Annual General Meeting of Shareholders of Elders Limited (Company)
will be held on Thursday 18 December 2025, commencing at 10am (ACDT)
in the City Room, Adelaide Convention Centre, North Terrace, Adelaide, South Australia 5000
Shareholders are encouraged to join virtually or in person
2025
Elders Limited ABN 34 004 336 636
17 November 2025
Dear Shareholder,
It is my pleasure to invite you to attend the 2025 Annual General Meeting (AGM) of Elders Limited (Elders), which will take place on
Thursday 18 December 2025 at 10.00am (ACDT). This Notice of Meeting and Explanatory Notes detail the business that will be dealt with at
that meeting.
I was honoured that the Board chose to appoint me as your new Chair, from 1 November this year. I look forward to the opportunity to
connect with shareholders at this AGM, just as I look forward to working with my fellow directors and management to guide the business
through its next stage.
Your Board is looking forward to meeting with you in person, while continuing to facilitate online attendees. We hope that this will mean as
many shareholders as possible will join and participate in the meeting.
Information about participation in the meeting, how to submit questions and voting on resolutions is set out in this Notice and further
detail can be found by visiting boardroomlimited.com.au/meeting/eldagm2025.
I encourage you to consider voting online ahead of the meeting, particularly if you are unable to join us at the prescribed time on
18 December 2025. If you attend the meeting and decide to change your vote, you can do so while voting remains open in the meeting.
At the 2024 AGM, shareholders voted against the adoption of the 2024 Remuneration Report. This followed a vote against the adoption of
the 2023 Remuneration Report and the granting of Service Rights to the MD and CEO, Mr Mark Allison.
Your Board notes that proxy advisor and major shareholder concerns primarily focused on the decisions made to retain Mr Allison’s
services and the subsequent honouring of those arrangements, rather than on general matters regarding KMP and executive remuneration
at Elders.
Proxy advisors and major shareholders indicated that the vote against the 2024 Remuneration Report was due to ongoing concerns about
the retention arrangements established for Mr Allison and the decision to uphold those commitments through alternative means. The
Board acknowledges these concerns regarding what were historic one-off decisions taken to address the circumstances and mitigate risks
associated with CEO succession at that time.
Mr Allison’s retention arrangements concluded in FY25. The board has heard shareholder concerns and will not grant retention payments
to senior executives without performance related targets in the future.
A detailed response to shareholder concerns is set out in Section 1 of Elders' 2025 Remuneration Report.
With a secure leadership team in place, and refreshed CEO succession plans being overseen by a Board that has continued its own
renewal process, your Board looks forward to an orderly process that will ensure the continuation of recent business success and improved
shareholder outcomes.
Your Board believes the resolutions proposed in the Notice and described in the Explanatory Notes are in the best interests of Elders’
shareholders and, subject to the abstentions stated in the Notice, unanimously recommends that you vote in favour of all Items. If you
appoint me as your proxy, or I become your proxy by default, but you do not direct me how to vote, I intend to vote in favour of all Items.
Thank you for your continued support of our great company.
Yours sincerely,
Glenn Davis
Chair
Elders Limited
ABN 34 004 336 636
Level 10, 80 Grenfell Street
Adelaide, SA, Australia 5000
GPO Box 551, Adelaide SA 5001
p | 08 8425 4000
elders.com.au
Notice of 2025 Annual General Meeting 3
Notice of 2025 Annual General Meeting
Agenda
Thursday, 18 December 2025
10.00 am ACDT
In the City Room, Adelaide Convention
Centre, North Terrace, Adelaide, South
Australia 5000 and online at https://
meetings.lumiconnect.com/
300-139-152-965
Shareholders are encouraged to join either
in person or online.
1. Financial Statements and Reports
To receive and consider the Financial
Statements and the Reports of the
Directors and Auditor for the 12 month
period ended 30 September 2025.
No vote is held in connection with this item.
2. Remuneration Report
To consider and, if thought fit, to pass the
following resolution:
“That the Remuneration Report, which
forms part of the Directors’ Report, for
the 12 month period ended 30 September
2025 be adopted.”
Note that the vote on this resolution
is advisory only and does not bind the
Company or the Directors of the Company.
3. Election of Bethwyn Todd
To consider and, if thought fit, to
pass the following resolution as an
ordinary resolution:
“That Bethwyn Todd, having been
appointed as a director by the Board
since the last Annual General Meeting, who
retires in accordance with Rule 8.1.5(a)
of the Constitution of the Company, and
being eligible, is elected as a director of
the Company.”
4. Election of Stephanie Nixon
To consider and, if thought fit, to
pass the following resolution as an
ordinary resolution:
“That Stephanie Nixon having been
appointed as a director by the Board
since the last Annual General Meeting, who
retires in accordance with Rule 8.1.5(a)
of the Constitution of the Company, and
being eligible, is elected as a director of
the Company.”
5. Managing Director’s Long-
Term Incentive
To consider and, if thought fit, to
pass the following resolution as an
ordinary resolution:
“That for the purposes of ASX Listing Rule
10.14, and for all other purposes, the
grant of 227,310 performance rights to
the Managing Director and Chief Executive
Officer, Mr Mark Charles Allison, on the
terms specified in the Explanatory Notes to
and forming part of the Notice of Meeting
be approved.”
6. Ratification of Prior Issue of Securities
To consider and, if thought fit, to
pass the following resolution as an
ordinary resolution:
“That for the purposes of ASX Listing Rule
7.4 and for all other purposes, approval is
given for the previous issue of securities as
described in the Explanatory Notes to and
forming part of the Notice of Meeting."
7. Approval of Financial Assistance
To consider and, if thought fit, to pass the
following resolution as a special resolution:
"That for the purposes of sections 260A
and 260B(2) of the Corporations Act
2001 (Cth), approval is given for the
financial assistance to be provided by
Delta Agribusiness Pty Ltd (ACN 118 781
445) and each of its Relevant Wholly-
Owned Subsidiaries in connection with the
Acquisition as described in the Explanatory
Notes to and forming part of the Notice
of Meeting."
Please refer to the accompanying
Explanatory Notes, which form part of this
Notice of Meeting, for more information on
the proposed resolutions.
By Order of the Board
Shannon Doecke
Company Secretary
17 November 2025
2025 Elders Notice of Annual General Meeting
4
Explanatory
Notes
The following notes form part
of the Notice of Meeting and
have been prepared to assist
shareholders to better understand
the business to be considered by
shareholders at the 2025 Annual
General Meeting. The Directors
recommend that shareholders
read the Explanatory Notes before
voting on the resolutions.
Item 1 — To Receive
and Consider the Financial
Statements and Reports of the
Directors and Auditor
In accordance with the requirements
of the Corporations Act 2001 (Cth)
(Corporations Act), the Financial
Statements and Reports of the Directors
and the Auditor for the 12 month period
ended 30 September 2025 will be laid
before the meeting.
Shareholders as a whole will be given
a reasonable opportunity at the meeting
to ask questions or make comments
on the management of the Company.
Shareholders may also submit written
questions to the Auditor relevant to the
content of the Auditor’s Report or the
conduct of the audit up to five business
days prior to the AGM. A reasonable
opportunity will be given at the AGM
for shareholders as a whole to ask the
Auditor or its representatives questions
relevant to the conduct of the audit, the
preparation and content of the Auditor’s
Report, the accounting policies adopted
by the Company in relation to the
preparation of the financial statements
and the independence of the auditor in
relation to the conduct of the audit.
Elders encourages all shareholders to elect
to receive documents by email to ensure
efficient and timely communication. The
2025 Annual Report (which includes
the Financial Statements and Reports
of the Directors and the Auditor) has
been emailed to shareholders who have
provided an email address and elected
to receive a digital copy. A digital
copy is also located on the Company’s
website at: https://investors.elders.com.au/
periodic-reports. A hard copy of the
2025 Annual Report will be mailed to all
shareholders who have elected to receive
a printed copy.
Neither the Corporations Act nor
the Company's Constitution requires
shareholder approval of these Statements
and Reports. Accordingly, no vote is held in
connection with this item.
Item 2 — To Adopt the
Remuneration Report
The Corporations Act requires the
Company to propose a resolution to
shareholders that the Remuneration
Report be adopted. The Remuneration
Report, which forms part of the Directors’
Report, can be found in the Company’s
2025 Annual Report.
The Remuneration Report includes:
1. an explanation of the Company’s policy
for determining the nature and amount
of remuneration of Key Management
Personnel (KMP);
2. a discussion of the relationship between
the remuneration policy, the Company’s
performance and KMP remuneration
outcomes; and
3. a detailed summary of remuneration
components for KMP including relevant
performance conditions.
Although the vote on this resolution is
advisory only and does not bind the
Company or its Directors, the Board will
take the outcome of the vote and the
views of shareholders into consideration
when reviewing remuneration policies
and practices.
At the 2024 AGM, shareholders voted
against the adoption of the 2024
Remuneration Report, which followed a
vote against the adoption of the 2023
Remuneration Report and the granting of
Service Rights to the MD and CEO, Mr
Mark Allison.
The Board notes that proxy advisor
and major shareholder concerns primarily
focused on the decisions made to retain
Mr Allison’s services and the subsequent
honouring of those arrangements, rather
than on general matters regarding KMP
and executive remuneration at Elders.
Proxy advisors and major shareholders
indicated that the vote against the
2024 Remuneration Report was due
to ongoing concerns about the
retention arrangements established for
Mr Allison and the decision to uphold
those commitments through alternative
means. The Board acknowledges these
concerns regarding what were historic
one-off decisions taken to address
the circumstances and mitigate risks
associated with CEO succession at
that time.
In terms of the cash retention payments
made to Mr Allison in FY25, the
board notes:
• the retention arrangements originally
agreed between the Company and Mr
Allison in June 2023 involved cash
payments and equity grants if he
remained employed on 1 June 2024 and
1 June 2025
• the equity grants were not approved at
the 2023 AGM
• in May 2024 the board determined,
and agreed with Mr Allison, to replace
the originally agreed equity grants with
cash payments of equivalent value if he
remained employed on 1 June 2024 and
1 June 2025
• that agreement was part performed in
June 2024 when Mr Allison remained
employed on 1 June 2024 and the first
retention payments were made
• Mr Allison remained employed on
1 June 2025
Notice of 2025 Annual General Meeting 5
and accordingly, the second and last cash
retention payment was made to Mr Allison
in June 2025.
All retention payments to Mr Allison have
now concluded.
Elders has taken on board the feedback
from shareholders and their proxy
advisors and will not grant retention
payments to senior executives without
performance related targets in the future.
A detailed response to shareholder and
proxy advisor concerns is set out in Section
1 of Elders' 2025 Remuneration Report.
With a secure leadership team in place,
and refreshed CEO succession plans being
overseen by a Board that has continued
its own renewal process, your Board
looks forward to an orderly process
that will ensure the continuation of
recent business success and improved
shareholder outcomes.
Voting Exclusion Statement
The Company will disregard any votes cast
on Item 2:
• by or on behalf of a member of the
KMP whose remuneration details are
included in the Remuneration Report (or
their closely related parties), regardless
of the capacity in which the vote is
cast; or
• by a member of the KMP (or their
closely related parties) at the date of the
meeting acting as proxy.
However, the Company need not disregard
a vote if:
• it is cast by a person as proxy for
a person who is entitled to vote, in
accordance with the directions on the
proxy form; or
• it is cast by the person chairing the
meeting as proxy for a person who is
entitled to vote, in accordance with an
express authorisation to vote as the
proxy decides even though Item 2 is
connected with the remuneration of a
member of the KMP.
The term ‘closely related party’ is defined
in the Corporations Act and includes
the KMP’s spouse, child, dependants and
certain other close family members, as well
as any companies controlled by the KMP.
Board Recommendation
Acknowledging that each director has
a personal interest in their own
remuneration from the Company as set
out in the Remuneration Report, the
Board unanimously recommends that
Shareholders vote in favour of adopting
the Remuneration Report.
Item 3 — Election of
Bethwyn Todd
Ms Todd was appointed to the Board
effective 2 January 2025. Ms Todd will
retire at the AGM in accordance with Rule
8.1.5(a) of the Company's Constitution and
will stand for election.
Bethwyn Todd
Ms Todd commenced as a non-executive
director of the Company on 2 January
2025. Ms Todd is the Chair of the
Safety and Sustainability Committee and a
member of the Audit, Risk and Compliance
Committee; the Remuneration and People
Committee; and the Nomination and
Prudential Committee. Ms Todd is also a
non-executive director of Lawson Grains
Pty Ltd.
Ms Todd has significant executive
experience, coupled with a strong
understanding of the agricultural and
chemical sectors. Ms Todd worked for
FMC Corporation in senior management
roles for approximately 12 years, most
recently as President of Asia Pacific and
Vice President FMC Corporation. She was
also President of CropLife Asia from 2019
to 2021.
Ms Todd brings to the Board skills
in strategy and planning, commercial
leadership, change and major project
delivery, safety, sustainability and
corporate affairs.
Ms Todd is a resident of Queensland.
Prior to her appointment, appropriate
checks were carried out relating to Ms
Todd's character, experience, education,
criminal record and bankruptcy history.
None of these checks revealed any
information of concern.
Ms Todd has confirmed to the Company
that she has sufficient time to fulfil
her duties as a director of Elders. She
has estimated her other commitments
to require approximately 60 hours
per month.
Board Recommendation
The Board considers that Ms Todd's
significant and proven skills and
experience will add significantly to Elders
and, therefore, the Board unanimously
recommends (with Ms Todd abstaining)
the election of Ms Todd as a director.
The Board considers Ms Todd to be an
independent director.
Item 4 — Election of
Stephanie Nixon
Stephanie Nixon was appointed to the
Board effective 1 October 2025. Ms Nixon
will retire at the AGM in accordance with
Rule 8.1.5(a) of the Company's Constitution
and will stand for election.
Stephanie Nixon
The Board appointed Ms Nixon as a
non-executive director effective 1 October
2025. Ms Nixon is a member of the
Safety and Sustainability Committee;
the Audit, Risk and Compliance
Committee; the Remuneration and People
Committee; and the Nomination and
Prudential Committee.
Ms Nixon brings to the Board significant
executive experience, having previously
held senior executive positions with
Compass Group Australia and Lion Pty Ltd.
Ms Nixon is a fellow of Certified Practising
Accountants, Australia and holds both a
Master of Management from Macquarie
University Graduate School and a Bachelor
of Business with Credit from the University
of Technology, Sydney. She is a graduate
and member of the Australian Institute
of Company Directors. Ms Nixon brings
to the Board skills in strategy, mergers
and acquisitions, financial and operational
governance, risk management, cyber
security and remuneration.
Ms Nixon is a resident of New
South Wales.
Prior to her appointment, appropriate
checks were carried out relating to Ms
Nixon's character, experience, education,
criminal record and bankruptcy history.
None of these checks revealed any
information of concern.
Ms Nixon has confirmed to the Company
that she has sufficient time to fulfil her
responsibilities as a director of Elders.
She has estimated her other commitments
require approximately 8 hours per month.
Board Recommendation
The Board considers that Ms Nixon's
extensive experience and skill set will
add to and compliment the existing skills
on the Board. The Board, therefore,
unanimously recommends (with Ms
Nixon abstaining) the election of Ms
Nixon as a director.
The Board considers Ms Nixon to be an
independent director.
2025 Elders Notice of Annual General Meeting
6
Item 5— Managing Director’s
Long-Term Incentive
On 5 June 2023, the Company advised
that after a comprehensive domestic and
international search for a CEO successor,
Mark Allison would continue in the role
of Managing Director and Chief Executive
Officer. Mr Allison has advised that he is
available to continue in the role until the
end of the current Eight Point Plan, which
concludes 30 September 2026.
The Board is conscious that the
appointment of Mr Allison’s successor will
be a significant step for the company
and is focussing on its commenced well-
structured CEO succession program to
identify the most suitable candidate.
During FY25, Mr Allison has been
instrumental in delivering forward-looking
initiatives that are expected to
benefit shareholders, including the
Systems Modernisation program and the
acquisition of Delta Agribusiness Pty Ltd.
The Board acknowledges the significant
contributions of Mr Allison and seeks to
ensure he is fairly remunerated while he
remains as Managing Director and Chief
Executive Officer.
The Board considers, in accordance
with generally accepted remuneration
practices in Australia, that an equity-
based Long-Term Incentive is integral
to linking the Managing Director and
CEO’s remuneration with long-term value
for shareholders. The Board continually
reviews the design of the remuneration
framework to ensure it:
• meets its objectives in supporting the
overall business strategy
• is aligned with shareholder interests
• is competitive and reflects
market practice
• is simple for both participants and
shareholders to understand
The Board anticipates that, following a
smooth transition of CEO, Mr Allison will
qualify as a ‘good leaver’. Dependent
on the portion of the performance
period served, the Board expects that
performance rights on foot at the date of
departure will be pro-rated in accordance
with the cessation of employment terms
outlined in the material terms of the plan
and will be tested in the ordinary course.
This approach is designed to ensure
that Mr Allison is remunerated fairly
for the responsibilities of his position,
while aligning his interests with those
of shareholders. The Board retains
discretion to make adjustments it
considers appropriate in light of the
purpose and intent of the plan, including
aligning outcomes with general market
and shareholder expectations.
Since 2021, shares have been purchased
on market to be allocated to participants
upon the vesting of performance rights.
Prior to this, shares were issued to
satisfy the vesting outcomes. Nonetheless,
shares to satisfy the vesting outcomes
under Elders' Long-Term Incentive Plan
(Plan) may either be purchased on market
or issued.
Shareholder approval is being sought
for the proposed grant of performance
rights to Mr Allison, pursuant to the
Plan, on the terms set out below and
in accordance with ASX Listing Rule
10.14. Listing Rule 10.14 provides that
a company must not permit a director
to acquire equity securities under an
employee incentive scheme without the
approval of shareholders. Shareholder
approval is required under Listing Rule
10.14.1 because Mr Allison is a Director of
Elders Limited.
Terms of proposed grant
Maximum number of
performance rights
The proposed grant is for 227,310 performance rights. The grant represents the LTI component of
the CEO’s remuneration package for the financial year ending 30 September 2026.
The maximum number of performance rights was calculated using a face value equivalent to the 5
trading day volume weighted average price as at 30 September 2025 ($7.440) rounded down to the
nearest 10 performance rights.
The performance rights will be granted at no cost to Mr Allison as they form part of his
remuneration package, and no amount is payable on vesting of the rights if the performance and
service conditions are met.
Subject to the satisfaction of the performance and service conditions below, each performance right
entitles Mr Allison to one fully paid ordinary share in the Company that carries the same rights as
other ordinary shares in the Company.
Under the Plan Rules, the Board has discretion to make a cash payment in lieu of an allocation
of shares.
Performance period The performance of each tranche against the applicable performance hurdle will be measured over
the three-year performance period from 1 October 2025 to 30 September 2028.
Rights attaching to
performance rights
Performance rights carry no voting or dividend entitlements until they vest into shares.
Mr Allison must not sell, transfer, encumber, hedge or otherwise deal with unvested
performance rights.
Date of issue If shareholder approval is obtained, the performance rights will be issued to Mr Allison shortly after
the AGM and no later than 28 February 2026.
Performance conditions The Board has determined that the grants will be divided into two tranches, each of which will
comprise 50% of the grant.
Tranche 1:
Relative TSR against
Comparator Companies
50% of the grant will be subject to Elders’ Total Shareholder Return (TSR) performance relative to the
TSR performance of the Comparator Companies.
The Comparator Group comprises the companies in the S&P/ASX 200 index as at the start of the
Performance Period. Any companies that are delisted from the ASX during the Performance Period
or suspended from trading at the end of the Performance Period will be removed from the vesting
assessment. The Board has absolute discretion over the calculation methodology and may adjust
the Comparator Companies to take into account events including, but not limited to, takeovers,
mergers or de-mergers that might occur during the performance period.
TSR is a measurement of the entire return a shareholder would obtain over the Performance
Period. The measure takes into account changes in the share’s market value, dividends paid and any
significant capital actions that occur during the period. The start and end share values are calculated
as the Volume Weighted Average Price over 5 trading days, respectively, at the start and end of the
Performance Period.
Notice of 2025 Annual General Meeting 7
Terms of proposed grant
The percentage of Mr Allison’s performance rights that will vest under Tranche 1 is set out in the
table below:
Elders’ TSR percentile
rank over the Performance Period
Percentage of Tranche 1
Performance Rights that vest
Less than 50th percentile 0%
At 50th percentile 50%
Between 50th and 75th percentile 50-100%, increasing on a pro-rata basis
At 75th percentile or above 100%
To ensure an objective assessment of the relative TSR comparison, Elders engages an independent
organisation to calculate the TSR ranking.
Gateway: Performance rights under this tranche will only vest in accordance with the above vesting
schedule if Elders’ absolute TSR over the Performance Period is greater than or equal to zero.
Tranche 2:
Earnings per share (EPS)
The remaining 50% of the grant will be subject to an EPS hurdle which measures Elders’ compound
annual EPS growth rate (EPS CAGR) over the performance period.
The EPS vesting schedule is as follows:
Target measure: 7.5% EPS CAGR over the performance period
Stretch measure: 10% EPS CAGR over the performance period
Actual EPS CAGR over
the Performance Period
Percentage of Tranche 2
Performance Rights that vest
Less than Target 0%
Target 50%
Between Target and Stretch 50-100%, increasing on a pro-rata basis
Stretch and above 100%
Unless the Board determines otherwise, NPAT used in determining EPS will be Underlying NPAT as
presented in the Company’s Annual Reports and shares issued will be the weighted average shares
outstanding for each period as per statutory reporting.
Opening EPS The opening EPS value used for the performance testing calculation will be the FY25 closing EPS
used to test the performance outcomes of the FY23 LTI grant, being 49.3c. At the date of printing,
this figure is subject to finalisation of the FY25 external audit including performance calculations.
The difference between reported FY25 EPS and the FY25 closing EPS used as the opening value for
this grant will be reconciled in the FY25 Remuneration Report.
Performance testing Testing of the performance conditions will occur once the results for the financial year ending
30 September 2028 have been approved by the Board. Performance rights will only vest once the
Board, in its discretion, determines that relevant conditions have been satisfied.
Any performance rights that do not vest will immediately lapse. There is no re-testing
of performance.
The Board may exercise discretion when testing performance conditions and determining
vesting outcomes.
Participants will be allocated one fully paid ordinary share in Elders for each performance right
that vests.
Restrictions and rights after vesting For performance rights that vest, shares will be allocated to Mr Allison. These shares will be held in
trust for an additional 12 month period and will be subject to a service condition. During this time,
Mr Allison will not be able to deal with these shares.
However, during the 12 month restriction period, Mr Allison will be entitled to receive dividends and
other distributions and have full voting rights in respect of any shares allocated to him on vesting of
the performance rights.
Once the 12 month holding restriction is lifted, Mr Allison will be free to deal with the shares
allocated, subject to the requirements of the Company’s Securities Dealing Policy.
Summary of the Material Terms of the Long-Term Incentive Plan
Offers under the Plan
and eligibility
The Board may invite Eligible Employees to participate in a grant of performance rights. Offers will be made on the terms
set out in the Plan and on any additional terms determined by the Board.
An Eligible Employee is an employee of the Elders Group, including a director employed in an executive capacity, or
any other person who is declared by the Board to be eligible to receive a grant of performance rights under the Plan.
Non-executive directors are not eligible to participate in the Plan.
In December 2023, shareholders approved the issue of securities under the Long-Term Incentive Plan as an exception
to Listing Rule 7.1. The explanatory notes to the 2023 Notice of Meeting advised that a maximum of 3,680,000
performance and service rights were proposed to be issued under the Long-Term Incentive Plan for the three years
ending 30 September 2024 to 30 September 2026. As Shareholders did not approve the resolution to grant Mr Allison
180,000 service rights, the maximum number of performance rights approved by shareholders is 3,500,000 for Eligible
Employees for years ending 30 September 2024-2026.
2025 Elders Notice of Annual General Meeting
8
Summary of the Material Terms of the Long-Term Incentive Plan
Vesting Restricted shares and performance rights granted under the Plan will only vest where any performance condition and any
other relevant conditions advised to the participant by the Board have been satisfied.
On vesting of a performance right, the Board will allocate the number of shares in respect of the performance rights
vested. Any shares issued under the Plan will rank equally in all respects with other shares on issue at that time (except as
regards any rights attaching to such shares by reference to a record date prior to the date of their issue).
Cessation of employment On cessation of employment due to:
• retirement
• genuine redundancy
• death or total and permanent disablement
• termination without cause,
then, subject to the Board's discretion to determine otherwise no later than 60 days after cessation of employment:
• shares held under the 12 month holding restriction will be released to the pa
Share your feedback
Discover